Intervivo Solutions

Intervivo Solutions is a contract research organization (CRO) specializing in neuroscience and translational research to support drug discovery and development. The company is widely recognized for its expertise in central nervous system (CNS) disorders, utilizing advanced animal models, including a unique aged canine model for Alzheimer's disease and cognitive dysfunction. Their services encompass pharmacokinetic (PK) studies, safety assessments, and efficacy testing using sophisticated behavioral and biomarker assays. By providing high-quality translational data, Intervivo helps clients bridge the gap between early-stage research and clinical success. In 2021, the company was acquired by Altasciences, integrating its specialized CNS capabilities into a broader clinical research platform.